Peripheral T-cell lymphoma: new therapeutic strategies.
作者： Adam M Petrich , Steven T Rosen
DOI:
关键词:
摘要: In this article we briefly review the labeled indications for new agents cutaneous and peripheral T-cell lymphoma, focus on data from last 1 to 2 years, ongoing clinical trials, with hope that in doing so can help elucidate difficult treatment decisions.
cancernetwork.com参考文章(46)
Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)
Ryuzo Ueda, Takashi Ishida, Genji Takeuchi, Masato Ito, Tadaaki Eimoto, Atsushi Wakita, Yoshifusa Takatsuka, Shinsuke Iida, Hiroshi Inagaki, Atae Utsunomiya, Shigeru Kusumoto, Hirokazu Komatsu, Shigeki Shimizu, Kouji Matsushima, Clinical Significance of CCR4 Expression in Adult T-Cell Leukemia/Lymphoma: Its Close Association with Skin Involvement and Unfavorable Outcome Clinical Cancer Research. ,vol. 9, pp. 3625- 3634 ,(2003)
Ping Zhu, Elke Martin, Jörg Mengwasser, Peter Schlag, Klaus-Peter Janssen, Martin Göttlicher, Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell. ,vol. 5, pp. 455- 463 ,(2004) , 10.1016/S1535-6108(04)00114-X
Abeer N. Abouyabis, Pareen J. Shenoy, Mary Jo Lechowicz, Christopher R. Flowers, Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States Leukemia & Lymphoma. ,vol. 49, pp. 2099- 2107 ,(2008) , 10.1080/10428190802455867
Franck Morschhauser, Olivier Fitoussi, Corinne Haioun, Catherine Thieblemont, Hang Quach, Richard Delarue, Sylvie Glaisner, Jean Gabarre, André Bosly, John Lister, Ju Li, Bertrand Coiffier, A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial European Journal of Cancer. ,vol. 49, pp. 2869- 2876 ,(2013) , 10.1016/J.EJCA.2013.04.029
Meletios Dimopoulos, Andrew Spencer, Michael Attal, H. Miles Prince, Jean-Luc Harousseau, Anna Dmoszynska, Jesus San Miguel, Andrzej Hellmann, Thierry Facon, Robin Foà, Alessandro Corso, Zvenyslava Masliak, Marta Olesnyckyj, Zhinuan Yu, John Patin, Jerome B. Zeldis, Robert D. Knight, Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma The New England Journal of Medicine. ,vol. 357, pp. 2123- 2132 ,(2007) , 10.1056/NEJMOA070594
JAEHWI SONG, JI HEON NOH, JONG HEUN LEE, JUNG WOO EUN, YOUNG MIN AHN, SU YOUNG KIM, SUG HYUNG LEE, WON SANG PARK, NAM JIN YOO, JUNG YOUNG LEE, SUK WOO NAM, Increased expression of histone deacetylase 2 is found in human gastric cancer Apmis. ,vol. 113, pp. 264- 268 ,(2005) , 10.1111/J.1600-0463.2005.APM_04.X
Paul A. Marks, Richard A. Rifkind, Victoria M. Richon, Ronald Breslow, Thomas Miller, William K. Kelly, Histone deacetylases and cancer: causes and therapies. Nature Reviews Cancer. ,vol. 1, pp. 194- 202 ,(2001) , 10.1038/35106079
Jessica Katz, John E. Janik, Anas Younes, Brentuximab Vedotin (SGN-35) Clinical Cancer Research. ,vol. 17, pp. 6428- 6436 ,(2011) , 10.1158/1078-0432.CCR-11-0488
V M Richon, Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor British Journal of Cancer. ,vol. 95, ,(2006) , 10.1038/SJ.BJC.6603463